Driehaus Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-135,381
Closed -$38.6M 460
2023
Q2
$38.6M Buy
+135,381
New +$37.6M 0.49% 53
2023
Q1
Sell
-45,726
Closed -$9.4M 449
2022
Q4
$9.4M Sell
45,726
-148,802
-76% -$37.6M 0.14% 211
2022
Q3
$54.1M Sell
194,528
-37,463
-16% -$9.53M 0.82% 22
2022
Q2
$44.4M Buy
231,991
+10,985
+5% +$1.94M 0.72% 30
2022
Q1
$45.8M Buy
221,006
+5,126
+2% +$845K 0.56% 39
2021
Q4
$38.5M Buy
215,880
+37,638
+21% +$7.42M 0.39% 80
2021
Q3
$36.7M Buy
178,242
+80,925
+83% +$15.9M 0.44% 67
2021
Q2
$18.5M Buy
+97,317
New +$15.9M 0.24% 140

Other funds holding SWAV

Driehaus Capital Management's SWAV Position: Q3 2023 in Review

Driehaus Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 135,381 shares — an estimated $38.6M sold.

Driehaus Capital Management first reported a position in SWAV in Q2 2021 and held it in 8 quarters. The position peaked at $54.1M in Q3 2022. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

  • Driehaus Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Driehaus Capital Management sold 135,381 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $38.6M.
  • Driehaus Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
  • Driehaus Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $54.1M in Q3 2022.
  • 412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on Driehaus Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.